The evidence of a crosstalk between the Hippo and ER signaling pathways is also supported by the studies on the G protein coupled estrogen receptor (GPER), which is a mediator of the genomic and non-genomic effects of estrogens, highly upregulated in breast cancer tissues [398]. This evidence concerns the gene ESR1 and breast carcinoma.